Arkolith/Insider Trading/FBRX/Form 4

Riley Antony A

CHIEF FINANCIAL OFFICERForte Biosciences, Inc. (FBRX) · full profile →Form 4 · filed Jan 2, 2026
Net Buying
Open-Market Buys
$255K
Open-Market Sells
$0
Net Open-Market Flow
$255K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 1, 2026Option exercise(M)375—$042K
Jan 1, 2026Tax withholding(F)154$27.27$4K42K
Dec 30, 2025Buy(P)10K$26.33$255K42K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 1, 2026Option exercise(M)375—$02K

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001339375-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML